Piroxicam-d3

Piroxicam-d3 (CP-16171-d3) is deuterium labeled Piroxicam. Piroxicam is a non-steroidal anti-inflammatory drugs, acts as a COX inhibitor, with IC50s of 47, 25 μM for human monocyte COX-1 and COX-2, respectively [1].

Product Specifications

CAS Number

[942047-64-5]

Product Name Alternative

CP-16171 D3

UNSPSC

12352005

Hazard Statement

H301

Target

COX

Type

Isotope-Labeled Compounds

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

Purity

99.68

Solubility

10 mM in DMSO|DMSO : 50mg/mL (ultrasonic) |H2O : 0.1mg/mL (ultrasonic)

Smiles

O=C(C1=C(O)C2=CC=CC=C2S(N1C([2H])([2H])[2H])(=O)=O)NC3=NC=CC=C3

Molecular Formula

C15H10D3N3O4S

Molecular Weight

334.36

Precautions

P264-P270-P330-P405-P501

References & Citations

[1]Kato M, et al. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J Pharm Pharmacol. 2001 Dec;53 (12) :1679-85.